scispace - formally typeset
K

Kitae Lim

Researcher at OSI Pharmaceuticals

Publications -  6
Citations -  129

Kitae Lim is an academic researcher from OSI Pharmaceuticals. The author has contributed to research in topics: NS5B & Carboxamide. The author has an hindex of 5, co-authored 6 publications receiving 124 citations.

Papers
More filters
Journal ArticleDOI

Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site

TL;DR: Through high throughput screening, substituted proline sulfonamide 6 was identified as HCV NS5b RNA-dependent RNA polymerase inhibitor and optimization of various regions of the lead molecule resulted in compounds that displayed good potency and selectivity.
Journal ArticleDOI

Novel (4-Piperidin-1-yl)-phenyl Sulfonamides as Potent and Selective Human β3 Agonists

TL;DR: N-Alkyl substitution on the 4-piperidin-1-yl-phenylamine further increased the beta(3) potency while maintaining the selectivity, and sulfonamide 48 is a potent full beta( 3) agonist with > 500-fold selectivity over beta(1)- and beta(2)-ARs.
Journal ArticleDOI

Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.

TL;DR: Optimization of various regions of the lead molecule using parallel synthesis resulted in 1,6-substituted naphthalenes 19d-i, which displayed good potency and were selective over elastase, trypsin, and chymotrypsin.
Journal ArticleDOI

Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.

TL;DR: Tetra substituted naphthalene 31 displayed potent activity with IC(50) of 120 nM against HCV NS5B enzyme and was selective over a panel of polymerases.
Journal ArticleDOI

Novel and selective calcitonin-inducing agents

TL;DR: It is found that certain di-n-butylxanthine sulfonamides 4 upregulate CT transcription in a CT-luciferase reporter gene assay (CT-luci) and increase the production and release of CT in aCT secretion/RIA test (CTS), and these compounds do not have potent PDE4 inhibitory activity.